181 related articles for article (PubMed ID: 35235139)
1. P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.
Han Y; Bai C; He XM; Ren QL
Purinergic Signal; 2023 Mar; 19(1):145-153. PubMed ID: 35235139
[TBL] [Abstract][Full Text] [Related]
2. Research Progress in the Relationship Between P2X7R and Cervical Cancer.
Tang Y; Qiao C; Li Q; Zhu X; Zhao R; Peng X
Reprod Sci; 2023 Mar; 30(3):823-834. PubMed ID: 35799022
[TBL] [Abstract][Full Text] [Related]
3. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
Giannuzzo A; Pedersen SF; Novak I
Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
[TBL] [Abstract][Full Text] [Related]
4. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Li Q; Zhu X; Song W; Peng X; Zhao R
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
[TBL] [Abstract][Full Text] [Related]
5. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
6. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.
Antonioli L; Giron MC; Colucci R; Pellegrini C; Sacco D; Caputi V; Orso G; Tuccori M; Scarpignato C; Blandizzi C; Fornai M
PLoS One; 2014; 9(12):e116253. PubMed ID: 25549098
[TBL] [Abstract][Full Text] [Related]
8. P2X7 targeting inhibits growth of human mesothelioma.
Amoroso F; Salaro E; Falzoni S; Chiozzi P; Giuliani AL; Cavallesco G; Maniscalco P; Puozzo A; Bononi I; Martini F; Tognon M; Di Virgilio F
Oncotarget; 2016 Aug; 7(31):49664-49676. PubMed ID: 27391069
[TBL] [Abstract][Full Text] [Related]
9. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
[TBL] [Abstract][Full Text] [Related]
10.
Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
[TBL] [Abstract][Full Text] [Related]
11. Magnesium sulfate inhibits inflammation through P2X7 receptors in human umbilical vein endothelial cells.
Ozen M; Xie H; Shin N; Al Yousif G; Clemens J; McLane MW; Lei J; Burd I
Pediatr Res; 2020 Feb; 87(3):463-471. PubMed ID: 31493768
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1
Ruiz-Ruiz C; García-Magro N; Negredo P; Avendaño C; Bhattacharya A; Ceusters M; García AG
Dis Model Mech; 2020 Oct; 13(10):. PubMed ID: 33174532
[TBL] [Abstract][Full Text] [Related]
13. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
[TBL] [Abstract][Full Text] [Related]
15. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Kan LK; Seneviratne S; Drummond KJ; Williams DA; O'Brien TJ; Monif M
Purinergic Signal; 2020 Sep; 16(3):327-336. PubMed ID: 32583309
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of purinergic P2X receptor 7 (P2X7R) decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in U251 glioblastoma cells.
Drill M; Powell KL; Kan LK; Jones NC; O'Brien TJ; Hamilton JA; Monif M
Sci Rep; 2020 Sep; 10(1):14844. PubMed ID: 32908225
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.
Recourt K; de Boer P; van der Ark P; Benes H; van Gerven JMA; Ceusters M; van Nueten L; Drevets WC; Bhatacharya A; Browning M; Jacobs GE
Transl Psychiatry; 2023 Jul; 13(1):266. PubMed ID: 37482560
[TBL] [Abstract][Full Text] [Related]
19. Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice.
Rodriguez-Alvarez N; Jimenez-Mateos EM; Engel T; Quinlan S; Reschke CR; Conroy RM; Bhattacharya A; Boylan GB; Henshall DC
Neuropharmacology; 2017 Apr; 116():351-363. PubMed ID: 28082183
[TBL] [Abstract][Full Text] [Related]
20. P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord.
Luo J; Lee S; Wu D; Yeh J; Ellamushi H; Wheeler AP; Warnes G; Zhang Y; Bo X
Cell Death Dis; 2013 Oct; 4(10):e829. PubMed ID: 24091672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
